| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.24B | — | +53.5% |
| Cost of Revenue | $796.4M | — | +60.7% |
| Gross Profit | $445.6M | — | +42.0% |
| R&D Expense | $22.7M | — | +29.7% |
| SG&A Expense | $227.2M | — | +36.7% |
| Operating Income | $195.7M | — | +50.5% |
| Pre-tax Income | $176.9M | — | +58.7% |
| Income Tax | $36.5M | — | +49.0% |
| Net Income | $142.4M | — | -60.5% |
| EPS (Basic) | $0.88 | — | -59.6% |
| EPS (Diluted) | $0.87 | — | -59.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $512.0M | +8.5% | +36.8% |
| Current Assets | $1.79B | +9.1% | -24.9% |
| Total Assets | $6.96B | +1.6% | +3.5% |
| Current Liabilities | $1.05B | +5.1% | +26.9% |
| Long-term Debt | $1.56B | -0.2% | -11.7% |
| Total Liabilities | $3.17B | +1.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $85.2M | — | +41.5% |
| Capital Expenditures | $36.1M | — | +71.1% |
| Investing Cash Flow | -$34.4M | — | -102.2% |
| Financing Cash Flow | -$99.2M | — | +79.5% |
| Free Cash Flow | $49.1M | — | +25.6% |
| +1.8% |
| Stockholders' Equity | $3.80B | +1.8% | +5.0% |